| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/14/2007 | US7256268 Human high affinity choline transporter |
| 08/14/2007 | US7256267 Polynucleotide encoding a novel human serpin secreted from lymphoid cells, LSI-01 |
| 08/14/2007 | US7256264 Receptor for IL-17 homologous polypeptides and uses thereof |
| 08/14/2007 | US7256263 High molecular weight Dermatophagoides proteins, and nucleic acids encoding them; used to treat and diagnose mite allergies |
| 08/14/2007 | US7256262 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/14/2007 | US7256260 Human p53 mutations and a genetic system in yeast for functional identification of human p53 mutations |
| 08/14/2007 | US7256258 Preparing stereospecific growth hormone releasing factor (GRF) for diagnosis and treatment of growth hormone deficiencies |
| 08/14/2007 | US7256254 For therapy and prophylaxis of myocarditis |
| 08/14/2007 | US7256253 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
| 08/14/2007 | US7256181 In situ supplying interferons; gene expression; gene therapy |
| 08/14/2007 | US7256172 Administering to animal, an amount of a peptide effective for mediating relaxation of airway, peptide is capable of activating an airway epithelium protease activated receptor-2 (PAR2) under conditions sufficient for activation of said PAR2 to occur, thereby mediating relaxation of airway |
| 08/14/2007 | US7256043 Transfection complexes |
| 08/14/2007 | US7256041 Culturing mammalian cells containing a nucleic acid construct including a selectable marker operably linked to a promoter that preferentially expresses the selectable marker in mammalian stem cells; isolating mammalian stem cells expressing the selectable marker |
| 08/14/2007 | US7256039 PRO4405 nucleic acids |
| 08/14/2007 | US7256038 Polypeptide display libraries and methods of making and using thereof |
| 08/14/2007 | US7256037 Modified vaccinia Ankara expressing p53 in cancer immunotherapy |
| 08/14/2007 | US7256036 Blocking receptor binding; gene therapy; gastrin releasing peptide |
| 08/14/2007 | US7256034 Inhibitor of cell proliferation and methods of use thereof |
| 08/14/2007 | US7256029 Genetically engineered lactococcus which produces a heteropolysaccharide for use in food processing; milk thickening; sweetness; milk chewability |
| 08/14/2007 | US7256023 PUFA polyketide synthase systems and uses thereof |
| 08/14/2007 | US7256022 Pufa polyketide synthase systems and uses thereof |
| 08/14/2007 | US7256018 L-threonine biosynthesis |
| 08/14/2007 | US7256017 Methods for generating lepidopteran-toxic polypeptides |
| 08/14/2007 | US7256015 TALL-1 receptor molecules and uses thereof |
| 08/14/2007 | US7256010 Nucleic acid sequences encoding melanoma associated antigen molecules, aminotransferase molecules, ATPase molecules, acyltransferase molecules, pyridoxal-phosphate dependant enzyme molecules and uses therefor |
| 08/14/2007 | US7256007 Methods of regulating cytokine signalling |
| 08/14/2007 | US7255997 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents |
| 08/14/2007 | US7255988 Use of α 1-antichymotrypsin polypeptides, or nucleic acids encoding them, or of a cell which is expressing an ACT polypeptide, or a nucleic acid encoding it, for treatment and/or prevention of diabetes-associated and/or arterial poorly healing wounds and for identifying pharmacologically active substances |
| 08/14/2007 | US7255987 Selecting a pig for breeding for the paternally imprinted QTL associated with larger muscle mass and decreased fat deposit by testing a sample from said pig for the presence of a quantitative trait locus (QTL) located at a Sus scrofa chromosome 2 mapping at position 2p1.7. |
| 08/14/2007 | US7255986 Compositions for the diagnosis and treatment of epizootic catarrhal enteritis in ferrets |
| 08/14/2007 | US7255866 Botulinum toxin therapy for fibromyalgia |
| 08/14/2007 | US7255865 Administering a Clostridium neurotoxin component using a needleless syringe to treat involunatary muscle contraction |
| 08/14/2007 | US7255864 Diagnostic reagent for hepatitis C virus infection |
| 08/14/2007 | US7255863 Group A streptococcal vaccines |
| 08/14/2007 | US7255862 ALVAC/FIV constructs |
| 08/14/2007 | US7255861 Preparations for inducing immunotolerance and uses therefor |
| 08/14/2007 | US7255855 Surface expression method of peptides P5 and Anal3 using the gene encoding poly-gamma-glutamate synthetase |
| 08/14/2007 | US7255854 Use of lymphotoxin-β receptor blocking agents for the treatment of antibody mediated immunological diseases |
| 08/14/2007 | US7255851 Non-invasive localization of a light-emitting conjugate in a mammal |
| 08/14/2007 | CA2394572C Fusion protein having enhanced in vivo activity of erythropoietin |
| 08/14/2007 | CA2240427C Growth hormone secretagogue receptor family |
| 08/14/2007 | CA2223176C Novel kappa receptor selective opioid peptides |
| 08/14/2007 | CA2188437C Dry prothrombin time assay |
| 08/09/2007 | WO2007090123A2 Mgra is a redox regulator of antibiotic sensitivity and virulence |
| 08/09/2007 | WO2007089899A2 Water-soluble (g protein)-coupled receptor protein |
| 08/09/2007 | WO2007089690A2 Tat-042 and methods of assessing and treating cancer |
| 08/09/2007 | WO2007089659A2 Tat-039 and methods of assessing and treating cancer |
| 08/09/2007 | WO2007089150A1 Means and methods for influencing interactions between dc-sign and dc-sign ligands |
| 08/09/2007 | WO2007089133A1 Means and methods for influencing interactions between dc-sign and dc-sign ligands |
| 08/09/2007 | WO2007088882A1 Polypeptide having affinity for envelope virus constituent and use thereof in transferring substance into cell |
| 08/09/2007 | WO2007088869A1 Method for producing denatured substance of lactalbumin |
| 08/09/2007 | WO2007088639A1 Substrate protein for m-phase kinase and use thereof |
| 08/09/2007 | WO2007088531A2 Pem-3-like polypeptides, complexes, and related methods |
| 08/09/2007 | WO2007088460A2 Tgf-beta modulators and use thereof |
| 08/09/2007 | WO2007088459A2 Transgenic animals defective for emilin protein with hypertensive phenotype |
| 08/09/2007 | WO2007088159A1 Methods of treating degenerative disorders with rac 1b inhibitor |
| 08/09/2007 | WO2007088051A2 Modulation of mdl-1 activity for treatment of inflammatory disease |
| 08/09/2007 | WO2007087679A1 Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefor v |
| 08/09/2007 | WO2007064859A3 Compound and method for suppressing retroviral replication |
| 08/09/2007 | WO2007064742A3 Identification of protective antigenic determinants of porcine reproductive and respiratory syndrome virus (prrsv) and uses thereof |
| 08/09/2007 | WO2007054820A3 Manufacture of vaccines that contain both hepatitis b virus surface antigen and surfactant |
| 08/09/2007 | WO2007051577A3 METHOD FOR THE PRODUCTION OF γ-LINOLENIC ACID AND/OR STEARIDONIC ACID IN TRANSGENIC BRASSICACEAE AND LINACEAE |
| 08/09/2007 | WO2007050513A3 Pseudomonas aeruginosa l-d carboxypeptidase a, expression and activity |
| 08/09/2007 | WO2007049065A3 Vwfa, collagen and kunitz domain containing protein |
| 08/09/2007 | WO2007045873A3 Medical uses and therapies based upon the action of azurocidin on igfbp-1 |
| 08/09/2007 | WO2007030473A3 Luciferases and methods for making and using the same |
| 08/09/2007 | WO2007028969A3 Anchoring disruption molecules |
| 08/09/2007 | WO2007020243A3 Vaccine based on virus-neutralizing antibodies |
| 08/09/2007 | WO2007016150A3 Mutated pseudomonas exotoxins with reduced antigenicity |
| 08/09/2007 | WO2006138520A3 Methods for isolating and concentrating biological materials using continuous-flow ultracentrifugation |
| 08/09/2007 | WO2006112550A3 A THERAPEUTIC AGENT FOR Aβ RELATED DISORDERS |
| 08/09/2007 | WO2006105315A3 Compositions and methods for regulating inflammatory responses |
| 08/09/2007 | WO2006101441A8 Method for protein purification comprising heat incubation in acetic acidic solution |
| 08/09/2007 | WO2006098887A3 Gene disruptions, compositions and methods relating thereto |
| 08/09/2007 | US20070186311 BETA 1,2-xylosyltransferase-gene from arabidopsis |
| 08/09/2007 | US20070186309 Isolated nucleic acid sequence encoding a viral movement protein is used for genetic engineering a plant which is resist to virus, viral disease; transgenic plants, seeds; exogenous gene expression; agriculture crops |
| 08/09/2007 | US20070186308 Stress-related polynucleotides and polypeptides in plants |
| 08/09/2007 | US20070186302 Genes that confer regeneration ability to plants, and uses thereof |
| 08/09/2007 | US20070186299 Knockout mouse for the tumor suppressor gene ANX7 |
| 08/09/2007 | US20070186296 Cloning, characterization, and application of tnfrsf19 in neurological disorders |
| 08/09/2007 | US20070186295 TAT-036 and methods of assessing and treating cancer |
| 08/09/2007 | US20070186294 TAT-030 and methods of assessing and treating cancer |
| 08/09/2007 | US20070186290 Diagnostic and therapeutic use of the human hif3alpha gene and proteins for neurodegenerative diseases |
| 08/09/2007 | US20070185321 Growth differentiation factor-8 |
| 08/09/2007 | US20070185316 such as malononitrile with an amine basic catalyst in a polar aprotic solvent to allow for oligosaccharide characterization, detection and purification; allows more convenient and low-level detection of oligosaccarides without pretreatment of the sample |
| 08/09/2007 | US20070185315 Novel albumins |
| 08/09/2007 | US20070185314 Crystals of LuxP and complexes thereof |
| 08/09/2007 | US20070185313 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
| 08/09/2007 | US20070185312 Nucleic acids encoding a G-protein coupled receptor involved in sensory transduction |
| 08/09/2007 | US20070185048 ATP-binding cassette transporter polypeptide which regulates metabolism of triglycerides; treatment of obesity and eating disorders |
| 08/09/2007 | US20070185030 Immune response suppressor and treatment of multiple sclerosis |
| 08/09/2007 | US20070185028 Compositions and methods for treatment of protein misfolding and protein aggregation diseases |
| 08/09/2007 | US20070185027 Antiviral agents for the treatment, control and prevention of infections by coronaviruses |
| 08/09/2007 | US20070185025 Filoviral immunosuppressive peptides and uses thereof |
| 08/09/2007 | US20070185021 Diabetogenic epitopes |
| 08/09/2007 | US20070185020 Methods and compositions for treating disorders of the extracellular matrix |
| 08/09/2007 | US20070185019 Novel antimicrobial peptides with heparin binding activity |
| 08/09/2007 | US20070185017 Compositions and methods for the treatment of immune related diseases |
| 08/09/2007 | US20070185010 Novel Polypeptide Hormone Phosphatonin |
| 08/09/2007 | US20070184530 Long-acting veterinary polypeptides and methods of producing and administering same |